Identification of a ternary protein-complex as a therapeutic target for K-Ras-dependent colon cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Cancer phenotypes are driven by multiple proteins, necessitating targeted therapies against interdependent molecular clusters.
• Mutated (MT) Ras proteins are difficult to target directly, making their effector interactions crucial for therapeutic intervention in Ras-dependent cancers.

Purpose of the Study:

• To identify and characterize novel therapeutic targets for K-Ras-dependent colon cancer.
• To investigate the role of the p38γ MAPK effector pathway in maintaining mutated K-Ras expression and promoting tumor growth.

Main Methods:

• Unbiased proteomic screening and immunoprecipitation assays to identify protein interactions.
• Functional assays to assess the role of the p38γ-Hsp90-K-Ras complex in cancer cell growth.
• In vitro and in vivo studies evaluating the efficacy of pharmacological inhibition.

Main Results:

• A novel ternary complex of p38γ MAPK, heat shock protein 90 (Hsp90), and K-Ras was identified specifically in K-Ras MT colon cancer cells.
• This complex, regulated by p38γ-induced Hsp90 phosphorylation, is essential for maintaining MT K-Ras protein stability and promoting Ras-dependent growth.
• Pharmacological inhibition of Hsp90 or p38γ disrupted the complex, reduced K-Ras expression, and selectively inhibited K-Ras MT colon cancer growth.

Conclusions:

• The p38γ-activated ternary complex represents a novel and druggable therapeutic target for K-Ras-dependent colon cancer.
• Targeting this complex offers a promising strategy for selective treatment of colon cancers with mutated K-Ras.